검색어 : 통합검색[649.1]
총 1,196건 중 1,000건 출력
, 15/100 페이지
-
141
- Atopic eczema in early childhood. Important pathogenic factors of atopic eczema are an inborn barrier disorder of the skin and external irritations. 1. Irritation caused by clothing Zu: Hj. Cremer (Seite 649)
- Abeck, D.; ; (Pädiatrische praxis, v.63, 2003, pp.665-665)
-
142
- Should <I>trans</I> fatty acids be viewed as membrane-active drugs?
- Katz, Arnold M.; ; (Atherosclerosis. Supplements, v.7, 2006, pp.41-42)
-
143
- Backpropagation of action potentials generated at ectopic axonal loci: hypothesis that axon terminals integrate local environmental signals
- Pinault, Didier; Corresponding author. Fax: +1 418 649-5910; (Brain research. Brain research reviews, v.21, 1995, pp.42-92)
-
144
- 셀레늄증기 다중광선레이저의 헬륨 순도에 따른 광이득과 출력특성
- 최상태; 경주대학교 컴퓨터전자공학부; (照明·電氣設備學會論文誌 = Journal of the Korean Institute of Illuminating and Electrical Installation Engineers, v.16, 2002, pp.60-65)
-
145
- Frailty and sarcopenia do not predict adverse events in an elderly population undergoing non-complex primary elective surgery for degenerative conditions of the lumbar spine
- Charest-Morin, Raphaë le; Street, John; Zhang, Honglin; Roughead, Taren; Ailon, Tamir; Boyd, Michael; Dvorak, Marcel; Kwon, Brian; Paquette, Scott; Dea, Nicolas; Fisher, Charles G.; Flexman, Alana M.; Corresponding author. Department of Orthopedic Surgery, Laval University, 1401 18e rue, Local B-2408, Qué bec, QC G1J 1Z4, Canada. Tel.: (1) 418-649-0252 ext 63169; fax: (1) 418-649-5567.; (The spine journal : official journal of the North American Spine Society, v.18, 2018, pp.245-254)
-
146
- LBA7 Nivolumab (NIVO) plus chemotherapy (Chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 study
- Janjigian, Y.Y.; Ajani, J.A.; Moehler, M.; Garrido, M.; Gallardo, C.; Shen, L.; Yamaguchi, K.; Wyrwicz, L.; Skoczylas, T.; Bragagnoli, A.; Liu, T.; Tehfe, M.; Elimova, E.; Li, M.; Poulart, V.; Lei, M.; Kondo, K.; Shitara, K.; ; (Annals of oncology : official journal of the European Society for Medical Oncology, v.32, 2021, pp.S1329-S1330)
-
147
- MO283IMPACT OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, ON TETANUS- AND DIPHTHERIA-TOXOID VACCINATION-ELICITED IMMUNE RESPONSES IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
- Barratt, Jonathan; Mathur, Mohit; Suzuki, Yusuke; Engler, Frank; Yarbrough, Jill; Sloan, Susan; Oldach, David; Leicester General Hospital, John Walls Renal Unit, Leicester, United Kingdom; Visterra Inc., Waltham, United States of America; Juntendo University Faculty of Medicine, Department of Nephrology, Tokyo, Japan; Certara USA Inc., Princeton, United States of America; Visterra Inc., Waltham, United States of America; Visterra Inc., Waltham, United States of America; Visterra Inc., Waltham, United States of America; (Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, v.36, 2021, pp.gfab104.0041)
-
148
- Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases
- Stieger, K; Mendes-Madeira, A; Meur, G L; Weber, M; Deschamps, J-Y; Nivard, D; Provost, N; Moullier, P; Rolling, F; 1INSERM UMR U649, CHU-Hotel Dieu, Nantes, France; [1] 1INSERM UMR U649, CHU-Hotel Dieu, Nantes, France [2] 2Etablissement Franç ais du Sang, Pays de la Loire, Nantes, France; 3CHU-Hotel Dieu, Service d'Ophtalmologie, Nantes, France; 3CHU-Hotel Dieu, Service d'Ophtalmologie, Nantes, France; 4Ecole Nationale Vé té rinaire de Nantes, Services d'Urgences, Nantes, France; [1] 1INSERM UMR U649, CHU-Hotel Dieu, Nantes, France [2] 2Etablissement Franç ais du Sang, Pays de la Loire, Nantes, France; 1INSERM UMR U649, CHU-Hotel Dieu, Nantes, France; [1] 1INSERM UMR U649, CHU-Hotel Dieu, Nantes, France [2] 2Etablissement Franç ais du Sang, Pays de la Loire, Nantes, France [3] 5Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA; 1INSERM UMR U649, CHU-Hotel Dieu, Nantes, France; (Gene therapy, v.14, 2007, pp.1668-1673)
-
149
- Abstract CT184: First-Line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis
- Shen, Lin; Bai, Yuxian; Lin, Xiaoyan; Li, Wei; Wang, Jufeng; Zhang, Xiaochun; Pan, Hongming; Bai, Chunmei; Bai, Li; Cheng, Ying; Zhang, Jingdong; Zhong, Haijun; Ba, Yi; Hu, Wenwei; Xu, Ruihua; Guo, Weijian; Qin, Shukui; Yang, Nong; Lu, Jianwei; Shitara, Kohei; Lei, Ming; Li, Mingshun; Bao, Nicole; Chen, Tian; Liu, Tianshu; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.CT184-CT184)
-
150
- Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy, safety, and subgroup analyses from CheckMate 649.
- Shitara, Kohei; Janjigian, Yelena Y.; Moehler, Markus H.; Garrido, Marcelo; Gallardo, Carlos; Shen, Lin; Yamaguchi, Kensei; Wyrwicz, Lucjan; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda Silva; Liu, Tianshu; Tehfe, Mustapha; Elimova, Elena; Soleymani, Samira; Lei, Ming; Kondo, Kaoru; Li, Mingshun; Ajani, Jaffer A.; National Cancer Center Hospital East, Kashiwa, Japan; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Johannes-Gutenberg University Clinic, Mainz, Germany; ; Clinica San Carlos de Apoquindo, Pontificia Universidad Cató lica, Santiago, Chile; ; Fundació n Arturo Ló pez Pé rez, Santiago, Chile; ; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China; ; The Cancer Institute Hospital of JFCR, Tokyo, Japan; ; Klinika Onkologii i Radioterapii, Narodowy Instytut Onkologii, Warszawa, Poland; ; II Klinika Chirurgii Ogó lnej, Gastroenterologicznej i Nowotworó w Układu Pokarmowego, Medical University of Lublin, Lublin, Poland; ; Fundacao Pio Xii Hosp Cancer De Barretos, Barretos, Brazil; ; Zhongshan Hospital Fudan University, Shanghai, China; ; Oncology Center-Centre Hospitalier de l’université de Mon; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.40, 2022, pp.240-240)
QUICK MENU
